Welcome to our dedicated page for Cadre Hldgs SEC filings (Ticker: CDRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the numbers behind Cadre Holdings鈥� body-armor and duty-gear business? Most investors start with the 10-K annual report, but finding contract-backlog disclosures or product-liability reserves can take hours. This page gathers every Cadre Holdings annual report 10-K simplified, each Cadre Holdings quarterly earnings report 10-Q filing and every Cadre Holdings 8-K material events explained in one place鈥攗pdated the moment they post to EDGAR.
Stock Titan鈥檚 AI reads the dense technical language and presents plain-English takeaways: raw-material cost trends, segment margin shifts and government-contract wins. Need to monitor Cadre Holdings insider trading Form 4 transactions? Our real-time alerts flag officer buys and sells so you can spot patterns before the market reacts. Trying to decode incentive plans in the Cadre Holdings proxy statement executive compensation? We highlight pay metrics tied to survivability-equipment backlog.
Use cases include:
- Compare quarter-over-quarter profitability without wading through footnotes.
- Track Cadre Holdings executive stock transactions Form 4 instantly.
- Download AI-curated excerpts to support competitor or supplier analysis.
Whether you鈥檙e searching for 鈥�understanding Cadre Holdings SEC documents with AI鈥� or detailed Cadre Holdings earnings report filing analysis, this page delivers comprehensive coverage鈥攏o jargon, no delays, just the disclosures that drive decisions.
Cadre Holdings' Schedule 13G/A shows that Warren B. Kanders beneficially owns 11,823,511 shares of common stock, representing 28.9% of the class. The total includes 10,216,192 shares held by Kanders SAF, LLC (reported as 25%), 1,305,650 shares in a Roth IRA, 45,584 shares held personally, and 232,635 shares underlying options that are exercisable or exercisable within 60 days and therefore counted. The filing also discloses excluded awards: 229,797 options not currently exercisable and 2,071,481 restricted stock awards not vested or vesting within 60 days. Mr. Kanders is shown with sole voting and dispositive power over 11,800,061 shares and shared voting/dispositive power over 23,450 shares.
Cadre Holdings, Inc. (CDRE) Form 4 filing: CEO, Chairman and 10% owner Warren B. Kanders reported the sale of 25,000 common shares on 06/23/2025. The transaction, coded 鈥淪鈥�, was executed at a weighted-average price of $32.78 per share through the insider-controlled entity Kanders SAF, LLC.
Following the disposition, Kanders鈥� reported beneficial ownership stands at 10,216,192 shares indirectly via Kanders SAF, LLC, 45,584 shares held directly, 1,305,650 shares held in his Roth IRA, and 23,450 shares held in his spouse鈥檚 Roth IRA, for an aggregate of approximately 11.59 million shares. The sale thus represents roughly 0.22 % of his total reported holdings, leaving his ownership well above the 10 % threshold.
No derivative securities were reported, and the footnotes confirm that the reported price is weighted across multiple trades ranging $32.67-$32.96. Kanders remains the sole manager of Kanders SAF, LLC and disclaims beneficial ownership beyond his pecuniary interest.
Key takeaway: The filing shows a modest insider sale in dollar terms (~$0.8 million) relative to Kanders鈥� large strategic stake, with no indication of broader changes in ownership structure or corporate strategy.
Cadre Holdings (CDRE) 鈥� Form 4 filed 06/23/2025. CEO, Chairman and 10% owner Warren B. Kanders disclosed two open-market sales executed through his controlled entity, Kanders SAF, LLC.
- 06/18/2025: 50,000 common shares sold at a weighted-average price of $33.95.
- 06/20/2025: 50,000 common shares sold at a weighted-average price of $33.01.
The combined 100,000-share disposal generated roughly $3.3 million in gross proceeds. Following the transactions, Kanders SAF鈥檚 holding declined to 10,241,192 shares. Additional positions remain unchanged: 45,584 shares held directly, 1,305,650 in Warren B. Kanders鈥� Roth IRA, and 23,450 in his spouse鈥檚 Roth IRA.
No derivative activity was reported, and the filing does not indicate the sales were made under a Rule 10b5-1 plan. While the sale size is modest relative to Kanders鈥� total ownership, it represents the first reported share reduction in 2025 and may be monitored by investors for sentiment signals.
FAQ
What is the current stock price of Cadre Hldgs (CDRE)?
What is the market cap of Cadre Hldgs (CDRE)?
